Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-14

Clinical Trial Update: A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind, active-control trial compares telmisartan, candesartan, and amlodipine, each alone or with metformin, in non-diabetic, obese…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Candesartan (candesartan)
  • Telmisartan (Telmisartan)
  • metformin (metformin)

Snippet

Sponsor: Third Military Medical University | Conditions: Hypertension, Obesity | Phase 4 | Status: COMPLETED